Summary. Concentrations of oxytocin in corpora lutea were reduced from 1706 to less than 15 ng/g wet wt after hysterectomy in sheep during the oestrous cycle. Hysterectomy also blocked the appearance of raised levels of oxytocin in ovarian and jugular venous plasma caused by cloprostenol. Administration of cloprostenol to hysterectomized ewes resulted in luteal regression, which occurred as rapidly as in intact animals. Therefore oxytocin in the corpus luteum during the oestrous cycle is unlikely to be involved in intraluteal events mediating prostaglandin-induced luteolysis.
Introduction
The high concentration of oxytocin in the ovine corpus luteum (Wathes & Swann, 1982; Flint & Sheldrick, 1982) may be involved in the process of luteal regression in 2 ways. Luteal oxytocin may act systemically to stimulate uterine secretion of prostaglandin (PG) F-2a, which is luteolytic (see Flint & Hillier, 1975) . The release of oxytocin from the corpus luteum in response to the luteolytic PGF-2a analogue, cloprostenol, and the secretion of PGF-2oc caused by oxytocin, suggest that positive feedback may operate between the ovary and the uterus to ensure the rapid progress of luteal regression (Flint & Sheldrick, 1983) . In addition to a systemic action, oxytocin may also have a local luteolytic effect on, or within, the luteal cells. Adashi & Hsueh (1981) have demonstrated inhibition by several neurohypophysial hormones, including oxytocin, of gonadotrophin-stimulated steroid synthesis by isolated rat Leydig cells in culture, and Tan, Tweedale & Biggs (1982a, b) have observed similar effects with oxytocin, using bovine and human luteal cells. We have found that when luteal function is prolonged by hysterectomy (Wiltbank & Casida, 1956) Flint & Sheldrick, 1983) to allow calculation of extraction losses. Homogenates were centrifuged at 10 000 g for 30 min at 4°C and the supernatants freeze-dried. The residues were reconstituted in 5 ml distilled water and centrifuged at 10 000 g for 30 min at 4°C. Supernatants were assayed immediately or stored at -20°C. Tissue extraction recoveries were 65-9 ± 40%.
Radioimmunoassays
Oxytocin was measured in plasma and corpus luteum extracts by radioimmunoassay (Sheldrick & Flint, 1981 ; Flint & Sheldrick, 1983) . Tissue extracts were assayed without further extraction (50 µ diluted solution/assay tube); oxytocin was extracted from samples of plasma by mixing with Vycor glass powder, as described previously. The sensitivity, inter-and intra-assay coefficients of variation and extraction efficiency (for Vycor-extracted plasma samples) were 1-8 pg/tube, 16-0%, 12-3% and 73-3 ± 1-1% (n = 15) respectively. Cross-reactions ([8Arg] oxytocin), Pro-Leu-Gly-NH2 (melanocyte hormone inhibitory factor; oxytocin 7-9), and porcine vasoactive intestinal peptide <0-01%.
Progesterone was measured in plasma by radioimmunoassay as previously reported (Sheldrick, Mitchell & Flint, 1980) . The sensitivity, inter-and intra-assay coefficients of variation and extrac¬ tion recoveries for the assays reported here were 5-2 pg/tube, 7-0%, 7-0% and 92-9 ± 1 -6%, respec¬ tively.
Results
The release of oxytocin from the ovary in response to a luteolytic dose of cloprostenol in intact ewes was absent in animals that had been hysterectomized (Text-figs 2a & b) . In the first experiment (Text- fig. 2a) fig. 2b ). In this experiment jugular venous progesterone concentrations were 2-47 ± 0-29 (n = 12) and 2-58 ± 0-24 (n = 12) ng/ml for the intact and hysterectomized groups respectively immediately before clopro¬ stenol treatment.
The lack of detectable secretion of oxytocin by the ovary after hysterectomy was reflected in a reduced level of oxytocin in the corpora lutea. In 3 sheep killed on Days 28, 53 and 56 after last oestrus the concentrations of oxytocin in luteal tissue were 11,5 and 7 ng/g wet weight respectively (compared to 1706 ± 494 ng/g in 13 intact ewes on Days 8-14 of the cycle). The luteal concentration of oxytocin in hysterectomized sheep after cloprostenol treatment was also lower than in intact controls (4-3 ± 0-7 ng/g, for hysterectomized ewes between 53 and 83 days after oestrus compared with 39 ± 16 ng/g in 5 intact animals between Days 11 and 14 after oestrus; oxytocin measured 40-50 min after administering 125 pg cloprostenol, in both groups).
To determine whether a high concentration of oxytocin in the corpus luteum was required for the luteolytic response to prostaglandin, rates of luteal regression induced by cloprostenol in 3 hysterectomized ewes 78, 79 and 104 days after last oestrus were compared with the response in 4 intact ewes on Day 8 of the cycle (Text-fig. 3 ). Plasma oxytocin levels in these ewes are included in (Flint & Sheldrick, 1982 (Adashi & Hsueh, 1981 ; Tan et al., 1982a, b) (Baird & Scaramuzzi, 1975; Acritopoulou, Haresign, Foster & Lamming, 1977) and in their inhibitory effects on LH-stimulated adenylate cyclase (Lahov, Freund & Lindner, 1976; Wakeling & Green, 1981a) . In bovine corpora lutea cloprostenol interacts with the same membrane receptor as native PGF-2a (Wakeling & Green, 1981b (1982) reported that 100 µg caused irreversible luteal regression in 94-6% of ewes treated.
An alternative mechanism by which luteal oxytocin might contribute to luteal regression is via a systemic action involving uterine secretion of PGF-2a, and evidence for such a role has been presented (Flint & Sheldrick, 1983) . Since ovarian blood flow drops at luteal regression (Mattner & Thorburn, 1969) a third mode of action, through vasoconstriction (Lloyd & Pickford, 1961) , also seems possible.
The reduction in the concentration of oxytocin in the corpus luteum after hysterectomy suggests that luteal synthesis and/or secretion of oxytocin may be influenced by a uterine factor. The absence of any arteriovenous concentration difference for oxytocin across the ovary after hysterectomy indicates that synthesis is more likely to be affected than secretion. If oxytocin is synthesized in the corpus luteum, as it is in the neurohypophysis, in the form of a prohormone (see Richter & Schmale, 1983) , then the effect of hysterectomy may be to change the processing of this precursor, rather than to prevent its synthesis.
